Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    CAFQ056A2223
Show Display Options
Rank Status Study
1 Completed Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders;   Anti-Dyskinesia Agents
Interventions: Drug: AFQ056;   Drug: Placebo

Indicates status has not been verified in more than two years